VR-CAP Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bortezomib, cyclophosphamide, doxorubicin, prednisone and rituximab that can be used for the treatment of mantle cell lymphoma.

**Synonyms:** - Bortezomib-Cyclophosphamide-Doxorubicin-Prednisone-Rituximab - Bortezomib-Cyclophosphamide-Doxorubicin-Prednisone-Rituximab Regimen - Bortezomib/Cyclophosphamide/Doxorubicin/Prednisone Plus Rituximab - Bortezomib/Cyclophosphamide/Doxorubicin/Prednisone/Rituximab - Bortezomib/Cyclophosphamide/Doxorubicin/Prednisone/Rituximab Regimen - Bortezomib/Rituximab/Cyclophosphamide/Doxorubicin/Prednisone - VR-CAP - VR-CAP - VR-CAP (rituximab-abbs) - VR-CAP (rituximab-arrx) - VR-CAP (rituximab-blit) - VR-CAP (rituximab-pvvr) - VR-CAP (rituximab-rite) - VR-CAP (rituximab-rixa) - VR-CAP (rituximab-rixi) - Velcade/Rituxan-Cyclophosphamide/Adriamycin/Prednisone